Medical Supplies

Anika to Issue Fourth-Quarter and Full-Year 2018 Financial Results and Business Highlights on Thursday, February 21

Retrieved on: 
Thursday, February 7, 2019
Surgery, Health, Biotechnology, Pharmaceutical, Medical Supplies, General Health, Telecommunications, Anika, Portishead, Toll-free telephone number, Webcast

ET to discuss its financial results, business highlights, and outlook.

Key Points: 
  • ET to discuss its financial results, business highlights, and outlook.
  • The conference call can be accessed by dialing 1-855-468-0611 (toll-free domestic) or 1-484-756-4332 (international).
  • A live audio webcast will be available in the "Investor Relations" section of Anika's website, www.anikatherapeutics.com .
  • An accompanying slide presentation also can be accessed via the Anika Therapeutics website.

Teleflex Announces Fourth Quarter and Full Year 2018 Earnings Conference Call Information

Retrieved on: 
Thursday, February 7, 2019
Surgery, Health, Biotechnology, Medical devices, Other Health, Medical Supplies, General Health, Teleflex, New York Stock Exchange, Economy of the United States, Economy of New York City, Companies

Teleflex Incorporated (NYSE: TFX) announced today that financial results for the fourth quarter and full year 2018 will be released before market open on Thursday, February 21, 2019.

Key Points: 
  • Teleflex Incorporated (NYSE: TFX) announced today that financial results for the fourth quarter and full year 2018 will be released before market open on Thursday, February 21, 2019.
  • An investor conference call will be held at 8:00 a.m. (ET) on Thursday, February 21, 2019.
  • Teleflex is a global provider of medical technologies designed to improve the health and quality of peoples lives.
  • Teleflex employees worldwide are united in the understanding that what we do every day makes a difference.

Innoviva Reports Fourth Quarter 2018 Financial Results

Retrieved on: 
Wednesday, February 6, 2019
Health, Pharmaceutical, Professional services, Banking, Finance, Medical Supplies, General Health, Ellipta

Innoviva, Inc. (NASDAQ: INVA) (the Company) today reported financial results for the fourth quarter ended December 31, 2018.

Key Points: 
  • Innoviva, Inc. (NASDAQ: INVA) (the Company) today reported financial results for the fourth quarter ended December 31, 2018.
  • Total operating expenses for the fourth quarter of 2018 were $2.6 million compared with $3.1 million (including $2.9 million for insurance recovery and legal fee discount) in the fourth quarter of 2017.
  • Total non-cash operating expenses for the fourth quarter of 2018 included $0.5 million in stock-based compensation compared to $2.4 million in stock-based compensation for the fourth quarter of 2017.
  • Fourth quarter 2018 net sales of ANORO ELLIPTA by GSK were $186.2 million, up 26% from $147.3 million in the fourth quarter of 2017, with $125.7 million net sales from the U.S. market and $60.5 million from non-U.S. markets.

Vizient, Inc. Joins Other Health Care Leaders to Support the CREATES Act

Retrieved on: 
Wednesday, February 6, 2019
Practice Management, Health, Hospitals, Public policy, Government, Healthcare reform, Congressional News, Views, Pharmaceutical, Medical Supplies, Draft:Vizient, Inc., Articles, Health care, Health professional, Medicine

Vizient, Inc ., joins more than 50 other health care leaders in voicing its strong support for the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.

Key Points: 
  • Vizient, Inc ., joins more than 50 other health care leaders in voicing its strong support for the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
  • Vizient applauds this legislation, which will help improve access and affordability for the health care providers we serve, and help them fulfill their mission to provide high quality health care to their patients and communities.
  • Vizient is the nations largest health care performance improvement company serving a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health care delivery networks and non-acute health care providers.
  • Vizients diverse membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $100 billion in annual purchasing volume.

Worldwide Blood Viscometer Market, 2019-2023 - Dominated by Anton Paar, Benson Viscometers, BioFluid Technology, China BeiJing Steellex Scientific Instrument, RheoSense, and Thermo Fisher Scientific - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 6, 2019
Health, Medical devices, Medical Supplies, Fluid mechanics, Measuring instruments, Liquids, Viscosity, Hematology, Hemorheology, Matter, Viscometer

Blood viscometer plays a major role in evaluating blood viscosity, which will further provide valuable information regarding the risk of vascular disorders.

Key Points: 
  • Blood viscometer plays a major role in evaluating blood viscosity, which will further provide valuable information regarding the risk of vascular disorders.
  • The increasing prevalence of vascular diseases is likely to positively affect the growth of the global blood viscometer market.
  • The significant increase in healthcare expenditure among various countries, which is likely to contribute to the global blood viscometer market.
  • Furthermore, advances in blood viscometer have increased the prices of these systems, thereby hindering the growth of the market.

3M Leadership Announcement

Retrieved on: 
Wednesday, February 6, 2019
Technology, Hardware, Health, Home Goods, Medical devices, Office Products, Manufacturing, Aerospace, Automotive Manufacturing, Chemicals, Plastics, Engineering, Professional services, Finance, Retail, Other Science, Construction & Property, Commercial Building & Real Estate, Medical Supplies, Science, Companies, Articles, Business, 3M, Renewable energy technology, Michael L. Eskew, Board of directors, Mikes

Under Inges leadership, 3M evolved into a more agile and competitive enterprise while generating tremendous value for customers and shareholders, said Mike Eskew, independent lead director for the 3M Board.

Key Points: 
  • Under Inges leadership, 3M evolved into a more agile and competitive enterprise while generating tremendous value for customers and shareholders, said Mike Eskew, independent lead director for the 3M Board.
  • Todays decision underscores the Boards confidence in Mikes leadership and strong character to lead3Minto the future as both CEO and chairman of the board.
  • Im very confident that 3Ms best days are ahead and Mike will do a fantastic job leading 3M into the future.
  • At its annual meeting in May, the 3M Board of Directors will consist of 12 members, 11 of whom will be independent directors.

2019 Study on Veterinary Surgical Sutures - Worldwide Market Size & Share (2018-2026): Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 6, 2019
Health, Medical Supplies, Veterinary, Surgery, Veterinary physician, Market share, Surgical suture, Economy

The "Global Veterinary Surgical Sutures Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Veterinary Surgical Sutures Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.
  • Enhancement in the field of suture manufacturing process coupled with availability of wide range of surgical sutures for veterinary applications identified as the key factors responsible for overall growth of veterinary surgical sutures market.
  • Thus, supportive health insurance policies for pets also trigger the veterinary surgical sutures market in the near future.
  • Global Veterinary Surgical Sutures Market: Market Dynamics and Future Outlook

Confluent Medical Technologies Launches the High-Performance Nitinol Tubing Center of Excellence; Acquires Tube Hollows International (THI) to Now Offer the Most Comprehensive Selection of Nitinol Tubing for High-Performance Implants.

Retrieved on: 
Tuesday, February 5, 2019
Health, Medical devices, Medical Supplies, Chemistry, Physical sciences, Alloys, Smart materials, Materials science, Nickel titanium, Solid-state chemistry, United States Navy, Tubing

The High-Performance Nitinol Tubing Center of Excellence has world-class internal capabilities that include:

Key Points: 
  • The High-Performance Nitinol Tubing Center of Excellence has world-class internal capabilities that include:
    High purity ELI Nitinol material.
  • With the recent acquisition of Tube Hollows International, Confluent Medical has the most comprehensive, best-in-class offering for Nitinol tubing processing.
  • The acquisition of Tube Hollows International has been a key piece in the development of the High-Performance Nitinol Tubing Center of Excellence.
  • Confluent Medicals High-Performance Nitinol Tubing Center of Excellence is ideally set up to support medical device companies that require world-class Nitinol tubing for their designs for long-term implantable applications within the heart and other critical structures.

ProAmpac Presents Packaging and Healthcare Solutions at MD&M West

Retrieved on: 
Tuesday, February 5, 2019
Health, Medical devices, Manufacturing, Chemicals, Plastics, Packaging, Textiles, Medical Supplies, General Health, Packaging, Labels, Packaging and labeling, Product management, Business, Economy, Microeconomics, Drug packaging, Child-resistant packaging

Over-the-counter ProAmpac provides flexible packaging solutions for leading over-the-counter pharmaceuticals: poly-coated one-side paper and paper/poly/foil/poly structures for single-dose packaging.

Key Points: 
  • Over-the-counter ProAmpac provides flexible packaging solutions for leading over-the-counter pharmaceuticals: poly-coated one-side paper and paper/poly/foil/poly structures for single-dose packaging.
  • Child-Resistant Flexible Packaging ProAmpacs Child-Resistant Reclosable Easy Open (CRREO) solutions are patented engineered designs used worldwide in consumer, agricultural, pharmaceutical and medical applications.
  • ProAmpac is a leading global flexible packaging company with a comprehensive product offering unparalleled in the industry.
  • We provide creative packaging solutions, industry-leading customer service and award-winning innovation to a diverse global marketplace.